Muscle fibre types are why one tissue can hold a posture for hours and also power a sprint start. Skeletal muscle is a mosaic of slow-twitch and fast-twitch fibres that differ in the myosin they contain, the fuel they burn and how quickly they tire. Fibre type is a standard readout in muscle, metabolic and aging research, including the cell and mouse studies of muscle signalling that peptide research draws on.
This guide covers how fibre types were classified, how they compare and are recruited, how the mix varies and changes, the molecular switches found in mice and how labs measure fibre type. (US sources write “muscle fiber types”.)
The short answer
- Adult human limb muscle has three main fibre types. Type I (slow-twitch), IIa (fast, oxidative) and IIx (fast, glycolytic) are named after the myosin heavy chain each contains, encoded by MYH7, MYH2 and MYH1.
- “Type IIb” is mostly a rodent fibre. IIb myosin (MYH4) is the main myosin in most rodent muscles but appears in only a few specialized human muscles; human fibres once labelled IIB turned out to express IIx myosin.
- Speed trades against stamina. Type I fibres are slow, fatigue-resistant and rich in mitochondria; IIx fibres reach about ten times the peak power of type I fibres but tire quickly; IIa fibres sit between.
- Recruitment follows motor-neuron size. Under Henneman’s size principle, small motor neurons supplying slow fibres fire first, and larger units of fast fibres join as more force is needed.
- The mix varies widely and is partly inherited. A Université Laval analysis attributed about 45% of the variance in type I proportion to inherited factors and about 40% to environment.
- Fibre type is plastic, within limits. Training most consistently shifts IIx toward IIa and disuse shifts fibres toward faster myosin; the molecular switches were mapped mainly in mice and cultured cells.
Skeletal muscle fibre types
Slow-twitch and fast-twitch fibres · types I, IIa and IIx (plus IIb in rodents)
- Defined by
- The myosin heavy chain (MyHC) isoform, which largely sets shortening speed
- Human limb muscle
- Type I (MYH7), IIa (MYH2), IIx (MYH1), plus hybrid fibres
- Rodent addition
- IIb (MYH4), the fastest isoform; rare in adult human muscle
- Recruitment rule
- Henneman’s size principle (1957): small, slow units first
- Heritability estimate
- About 45% of the variance in type I proportion (1995)
- Key regulators
- Calcineurin–NFAT, MEF2, PGC-1α, PPARδ, AMPK–SIRT1
Where the evidence stands
- Fibre types described in human biopsies
- Training and aging shifts measured in people
- Molecular switches shown in mice and cells
- An approved medicine that targets fibre type
Fibre types are textbook physiology; their molecular switches were mapped mainly in mice and cultured cells.
What muscle fibre types are
A skeletal muscle fibre is a single long cell with many nuclei. “Fibre type” is shorthand for properties that travel together: contraction speed, power, how the fibre regenerates ATP and how long it keeps working. Today the type is defined by one protein, the myosin heavy chain (MyHC); in 1967 Bárány showed that myosin’s ATPase activity is higher in fast muscles and tracks shortening speed.
Mammalian muscles express 11 sarcomeric MyHC genes, but adult human trunk and limb muscle mainly uses three: slow MyHC-I (MYH7) and fast MyHC-IIa (MYH2) and MyHC-IIx (MYH1). Type I fibres are slow-twitch; IIa and IIx are both fast-twitch, IIa being more oxidative and IIx faster and more glycolytic. Some fibres are hybrids containing two isoforms; a 1994 mapping of human muscle found three pure populations and two kinds of hybrid.
How fibre types were classified: from red muscle to myosin genes
In 1873 Ranvier distinguished slow-contracting red muscles, highly vascularized and rich in myoglobin, from fast white muscles rich in glycolytic enzymes. In 1970 Michael Brooke and Kenneth Kaiser typed fibres in human biceps biopsies and in rat and rabbit muscle using the myosin ATPase reaction and its sensitivity to pH. Stains of this kind sorted fibres into types I, IIA and IIB: slow-oxidative, fast-oxidative-glycolytic and fast-glycolytic.
Anti-myosin antibodies introduced in 1989 then revealed an additional fast isoform, IIx, with its own gene, and in 1994 Smerdu and colleagues showed that the human fibres histochemists had called IIB are the ones rich in IIx message. Human muscle, like that of other large mammals, contains type I, IIa and IIx fibres. True IIb myosin dominates most rodent muscles but appears in only a few specialized human muscles; its human promoter is far less active than the mouse version, which researchers attribute to lost binding sites for the transcription factors MEF2 and SRF.
Reading older papers. In older human studies, “type IIB” means IIx. Rodent IIb fibres are a genuinely different, faster type, one reason mouse fibre-type results do not transfer directly to people; see how to read a peptide study.
Type I vs IIa vs IIx: the properties compared
The three types form a spectrum with IIa in the middle. IIx fibres shorten fastest and reach about ten times the peak power of type I fibres. Force differs less than often assumed: in isometric contractions slow fibres develop slightly lower tension than fast fibres, at a much lower energy cost.
| Property | Type I (slow-twitch) | Type IIa (fast) | Type IIx (fast) |
|---|---|---|---|
| Myosin heavy chain (gene) | MyHC-I (MYH7) | MyHC-IIa (MYH2) | MyHC-IIx (MYH1) |
| Shortening speed | Slowest | Intermediate | Fastest in human muscle |
| Peak power | Lowest | Intermediate | About ten times type I |
| Fatigue resistance | High | Intermediate to high | Low |
| Mitochondria | Abundant | Moderate to abundant | Fewest |
| Capillaries and myoglobin | Dense; the classic “red” profile | Intermediate | Sparse; the classic “white” profile |
| Main ATP source | Mitochondrial oxidation, notably of fatty acids | Oxidative and glycolytic | Glycolysis, drawing on glycogen |
| Recruited | First, at low force | As force rises | Last, for brief high force or power |
Values describe typical pure fibres; hybrids fall between them.
Motor units and Henneman’s size principle
A motor unit is one motor neuron plus every fibre it supplies, and a unit’s fibres share one fibre type, so the nervous system recruits fibre types by recruiting motor units. In 1957 Henneman reported that a neuron’s size governs its susceptibility to discharge. Small motor neurons have low thresholds, are recruited first and supply slow fibres; as force demand grows, larger units are added in order, from the weakest and most fatigue-resistant to the strongest and most fatigable.
In rats, slow units fire at about 15–20 Hz for hours, while fast units fire in brief, high-frequency bursts that add up to between half a minute and three minutes in a day. Use also helps set fibre type, through the calcium-dependent signalling described below.
The fibre-type mix in people and athletes
Muscles differ: in a 1974 study the human soleus averaged 80% slow-twitch fibres (range 64 to 100%), while the gastrocnemius and vastus lateralis averaged 57% (range 34 to 82%). So do people. In 1995 Jean-Aimé Simoneau and Claude Bouchard of Université Laval in Quebec estimated that about 25% of North American Caucasian men and women have under 35% or over 65% type I fibres in the vastus lateralis. They attributed about 15% of the variance to measurement error, 40% to environment and 45% to inherited factors.
A 2015 case study of a world-champion sprint hurdler found 71% fast-twitch fibres in his vastus lateralis, including 24% pure IIx fibres, whose power was about 14 times that of his type I fibres. A 2011 Belgian study found that sprinters had on average 1.9 times the muscle carnosine of marathon runners and triathletes, a marker of a faster fibre profile.
ACTN3: research, not destiny
α-Actinin-3 is a sarcomere protein expressed only in type II fibres. In 1999 Kathryn North and colleagues reported a common nonsense variant, ACTN3 R577X; people with two copies (the XX genotype) are deficient in the protein. Later studies found this genotype in roughly 18% of Caucasian, 25% of Asian and 11% of Ethiopian people. Elite sprinters carry the R allele more often than controls, and the X allele has been associated with a lower fast-twitch fibre percentage. Yet a 2017 review calls the sprint and power findings “not unequivocal” and the use of such information in sport speculative, and the Laval team estimated that environment and activity alone could explain a difference of about 30% in type I fibres.
How fibre type changes: training, disuse and aging
Training. A 2021 review of longitudinal human studies calls the shift from IIx toward IIa “a hallmark adaptation” of the first months of endurance and resistance training. Shifts between type II and type I are less consistent: the review finds pure type I fibres relatively resistant to change, and it describes an apparent IIx overshoot after training and detraining.
Disuse. The same review calls the shift toward faster myosin during disuse well characterized, and in regenerating rodent muscle without its nerve, fast isoforms predominate.
Aging. A 2013 study concluded that the decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II fibre size.
Size is not type. A fibre can enlarge or shrink without changing its myosin; hypertrophy (fibre enlargement) and fibre-type conversion are driven by partly separate signalling, as the IGF-1 culture work below shows.
The molecular switches: calcineurin, MEF2, PGC-1α and AMPK
The evidence here comes mainly from engineered mice and cultured muscle cells.
Calcineurin and NFAT. Slow fibres maintain higher intracellular calcium than fast ones. In 1998 Chin, Olson, Williams and colleagues showed that the calcium-regulated phosphatase calcineurin switched on slow-fibre promoters in cultured muscle cells through NFAT and MEF2 transcription factors, and that blocking it with cyclosporin A in intact animals promoted slow-to-fast conversion.
PGC-1α. In 2002 Bruce Spiegelman’s group reported that in transgenic mice expressing the co-activator PGC-1α at physiological levels, normally fast muscles became redder, switched on mitochondrial genes and slow-fibre proteins such as myoglobin, and became much more resistant to electrically stimulated fatigue. PGC-1α cooperated with MEF2 and was a target of calcineurin signalling.
PPARδ, AMPK and SIRT1. Deleting the nuclear receptor PPARδ from muscle shifts fibres toward a glycolytic, fast profile. In mouse muscle, the energy sensor AMPK raises cellular NAD+, increasing the activity of the deacetylase SIRT1, which deacetylates and activates PGC-1α; see our explainers on AMPK, the cell’s energy sensor, and the sirtuins.
MOTS-c, a 16-amino-acid peptide encoded in mitochondrial DNA, appeared in 2015 work to act mainly on skeletal muscle in mice and activated AMPK in cells. A 2021 study found that exercise raised the body’s own MOTS-c in human muscle and blood, and that MOTS-c improved physical capacity in young, middle-aged and old mice. Neither study measured fibre-type conversion in people; our MOTS-c research guide and overview of mitochondrial-derived peptides go further.
The “exercise mimetic” experiments in mice
In 2008 Ronald Evans’s laboratory reported that a PPARδ agonist plus exercise training synergistically increased oxidative fibres and running endurance in mice, and that four weeks of the AMPK agonist AICAR raised running endurance by 44% in sedentary mice. A 2021 review is more cautious: most candidate “exercise pills” act on muscle and reproduce only some training adaptations, missing exercise’s effects on the heart, blood vessels and other organs.
IGF-1: fibre size, not fibre type
In cultured C2C12 myotubes, IGF-1-induced hypertrophy ran through Akt to the mTOR pathway and to inhibition of GSK3; calcineurin was not required, and IGF-1 antagonized calcineurin signalling. The long-acting analogue Long R3 IGF-I was characterized in 1992 in L6 rat myoblasts, where it was more potent than IGF-I, a property linked to weaker binding to IGF-binding proteins. This is cell-culture evidence; see what IGF-1 is, the IGF-1 LR3 research guide and mTOR explained.
IGF-1 LR3 and other growth-signalling reagents for cell-culture research are stocked as laboratory materials, priced in CAD.
Browse growth & signallingHow fibre type is measured
Most human fibre-type data begin with a needle biopsy, and Canadian labs have refined the methods: a McMaster University team in Hamilton reported 13,500 suction-modified Bergström biopsies over 21 years, fewer than 0.1% of them inadequate, and Darin Bloemberg and Joe Quadrilatero at the University of Waterloo developed multicolour immunofluorescence that types rat, mouse and human fibres on one section.
| Method | What it reads | Main limitation |
|---|---|---|
| Myosin ATPase histochemistry | ATPase activity and its pH sensitivity, on serial frozen sections | Several sections and incubations; needs meticulous precision |
| MyHC immunofluorescence | Each isoform directly, in several colours on one section | Antibody panels differ by species; may miss low-level co-expression in hybrids |
| SDS-PAGE of myosin heavy chains | Isoforms separated by electrophoresis, in homogenates or single fibres | Homogenates hide hybrids; how many single fibres are needed is unsettled |
| Single-fibre proteomics | Thousands of proteins per fibre type | Misses proteins expressed in low amounts |
| Carnosine proton MR spectroscopy | Muscle carnosine as a non-invasive proxy for fast-fibre content | Validated against biopsies in only 12 untrained men (r = 0.714 with type II fibre area) |
Single-fibre studies of human muscle have also found α-actinin-3, the ACTN3 protein, enriched in IIx fibres.
What’s established and what isn’t
Reasonably well established
- Human limb muscle contains type I, IIa and IIx fibres; IIb is essentially a rodent type.
- Type I fibres are slower, more oxidative and more fatigue-resistant; IIx fibres are the fastest and most powerful.
- Motor units are recruited in order of size, slow units first.
- Training most consistently shifts IIx toward IIa; disuse shifts fibres toward faster myosin.
- Calcineurin–NFAT, MEF2, PGC-1α and PPARδ promote the slow, oxidative profile in mice and cultured cells.
Open questions
- How much between-person variation is inherited; the 45% figure comes from one 1995 analysis.
- How far and how consistently adult training shifts fibres between type II and type I.
- How much ACTN3 and other variants matter; the sprint and power findings are mixed.
- Whether switches mapped in mice work the same way in human muscle.
- Whether exercise-mimetic compounds, or MOTS-c’s mouse findings, have human counterparts.
Sourcing muscle-signalling reagents in Canada
Fibre-type work rests on tissue, antibodies and cell lines; peptides and growth factors enter in culture experiments, where documentation matters most.
- Match identity testing to the molecule. A protein-sized analogue such as IGF-1 LR3 needs mass spectrometry that confirms the full-length molecule; see LC-MS explained.
- Match the batch number on the certificate to the vial, as the peptide COA guide explains.
- Keep lyophilized material cold, dry and dark; see the peptide storage guide.
- Check the supplier’s documentation; see research peptides in Canada.
IGF-1 LR3Long R3 IGF-I analogue, characterized in L6 rat myoblast cultures in 1992View product
MOTS-cMitochondrial-encoded peptide studied in mouse skeletal muscle metabolismView product
NAD+The SIRT1 cofactor in the AMPK–SIRT1–PGC-1α pathway studied in mouse muscleView product
Research use only. Pure Peptides Canada products are laboratory reagents for in-vitro research, not for human or veterinary use. This article explains published research for education; it is not medical, dietary or dosing guidance.
Frequently asked questions
What are the three types of muscle fibres?
Adult human limb muscle contains type I, IIa and IIx fibres, named after the myosin heavy chain each contains. Type I fibres are slow-twitch, oxidative and fatigue-resistant; IIx fibres are the fastest and most powerful but tire quickly; IIa fibres are fast but more oxidative.
What is the difference between fast-twitch and slow-twitch muscle fibres?
Slow-twitch (type I) fibres have slow myosin, many mitochondria and dense capillaries, and make ATP mainly by oxidative metabolism, so they can work for long periods. Fast-twitch (type II) fibres have faster myosin and rely more on glycolysis; human IIx fibres reach about ten times the peak power of type I fibres.
Do humans have type IIb muscle fibres?
Essentially not in limb muscle. IIb myosin, encoded by the MYH4 gene, is the main myosin in most rodent muscles but appears in only a small set of specialized human muscles. Human fibres labelled IIB by older staining methods are rich in IIx myosin transcripts, so “IIB” in older human studies usually means IIx.
Can muscle fibre type change?
Within limits. Human training studies most consistently show IIx fibres shifting toward IIa within the first months of endurance or resistance training, and disuse shifts fibres toward faster myosin. Shifts between type II and type I fibres are less consistent; a 2021 review found pure type I fibres relatively resistant to change.
Is muscle fibre type genetic?
Partly. A 1995 Université Laval analysis attributed about 45% of the variance in type I fibre proportion to inherited factors, 40% to environment and 15% to measurement error. The ACTN3 R577X variant, which leaves roughly 18% of Caucasian people deficient in the fast-fibre protein alpha-actinin-3, is associated with fibre type and sprint status, but a 2017 review judged the evidence mixed.
Which muscle fibres are recruited first?
Slow, type I motor units. Under Henneman’s size principle, small motor neurons have the lowest thresholds and supply slow, fatigue-resistant fibres, so they carry low-force activity. Larger units built from fast fibres are added as force rises, and the most fatigable units are called on only briefly, for high force or power.
Growth-signalling reagents for muscle cell research
IGF-1 LR3 and the rest of the growth and signalling range, priced in Canadian dollars and shipped tracked from inside Canada. You can pay by credit or debit card, Interac e-Transfer or cryptocurrency at checkout.
References
- Henneman E. Relation between size of neurons and their susceptibility to discharge. Science. 1957;126(3287):1345–1347. DOI
- Brooke MH, Kaiser KK. Muscle fiber types: how many and what kind? Arch Neurol. 1970;23(4):369–379. DOI
- Gollnick PD, Sjödin B, Karlsson J, Jansson E, Saltin B. Human soleus muscle: a comparison of fiber composition and enzyme activities with other leg muscles. Pflügers Arch. 1974;348:247–255. DOI
- Francis GL, Ross M, Ballard FJ, et al. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J Mol Endocrinol. 1992;8(3):213–223. DOI
- Smerdu V, Karsch-Mizrachi I, Campione M, Leinwand L, Schiaffino S. Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. Am J Physiol. 1994;267(6 Pt 1):C1723–C1728. DOI
- Simoneau JA, Bouchard C. Genetic determinism of fiber type proportion in human skeletal muscle. FASEB J. 1995;9(11):1091–1095. DOI
- Chin ER, Olson EN, Richardson JA, et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 1998;12(16):2499–2509. DOI
- North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S, Beggs AH. A common nonsense mutation results in α-actinin-3 deficiency in the general population. Nat Genet. 1999;21(4):353–354. DOI
- Rommel C, Bodine SC, Clarke BA, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 2001;3(11):1009–1013. DOI
- Lin J, Wu H, Tarr PT, et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature. 2002;418(6899):797–801. DOI
- Narkar VA, Downes M, Yu RT, et al. AMPK and PPARδ agonists are exercise mimetics. Cell. 2008;134:405–415. DOI
- Cantó C, Gerhart-Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009;458(7241):1056–1060. DOI
- Baguet A, Everaert I, Hespel P, Petrovic M, Achten E, Derave W. A new method for non-invasive estimation of human muscle fiber type composition. PLoS One. 2011;6(7):e21956. DOI
- Harrison BC, Allen DL, Leinwand LA. IIb or not IIb? Regulation of myosin heavy chain gene expression in mice and men. Skelet Muscle. 2011;1:5. DOI
- Tarnopolsky MA, Pearce E, Smith K, Lach B. Suction-modified Bergström muscle biopsy technique: experience with 13,500 procedures. Muscle Nerve. 2011;43(5):716–725. DOI
- Fuglevand AJ. Mechanical properties and neural control of human hand motor units. J Physiol. 2011;589(23):5595–5602. DOI
- Bloemberg D, Quadrilatero J. Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis. PLoS One. 2012;7(4):e35273. DOI
- Nilwik R, Snijders T, Leenders M, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol. 2013;48(5):492–498. DOI
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443–454. DOI
- Trappe S, Luden N, Minchev K, Raue U, Jemiolo B, Trappe TA. Skeletal muscle signature of a champion sprint runner. J Appl Physiol. 2015;118(12):1460–1466. DOI
- Pickering C, Kiely J. ACTN3: more than just a gene for speed. Front Physiol. 2017;8:1080. DOI
- Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12:470. DOI
- Hawley JA, Joyner MJ, Green DJ. Mimicking exercise: what matters most and where to next? J Physiol. 2021;599(3):791–802. DOI
- Plotkin DL, Roberts MD, Haun CT, Schoenfeld BJ. Muscle fiber type transitions with exercise training: shifting perspectives. Sports (Basel). 2021;9(9):127. DOI
- Schiaffino S, Chemello F, Reggiani C. The diversity of skeletal muscle fiber types. Cold Spring Harb Perspect Biol. 2025;17(8):a041477. DOI
For laboratory research use only. Not for human or veterinary use. This article summarizes published research for educational purposes and is not medical advice.
